AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today ...
AtriCure announced the successful first-in-human AFib treatments using its novel dual-energy surgical cardiac ablation platform.
BSX builds momentum in PFA as FARAPULSE posts strong growth, and new trial results and expanded FDA labeling boost its AF ...
Learn more about whether Alphatec Holdings, Inc. or AtriCure, Inc. is a better investment based on AAII's A+ Investor grades, ...
Learn more about whether AtriCure, Inc. or Masimo Corporation is a better investment based on AAII's A+ Investor grades, ...
MedPage Today on MSN
Uterine Fibroids Point to Risk of Heart Disease Down the Line
This increased risk held across all individual components of the composite ASCVD endpoint (coronary artery disease, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback